Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants

Re Mee Doh, Hye Jeong Park, Yumie Rhee, Hyun Sil Kim, Jisun Huh, Wonse Park

Research output: Contribution to journalArticle

8 Citations (Scopus)


This report describes a case of teriparatide (TPTD) therapy for bisphosphonate (BP)-related osteonecrosis of the jaw induced after implant placement. A 75-year-old woman taking oral BP was referred with uncontrolled osteonecrosis of the mandible related to the implant placement. With conservative treatment, BP was suspended and daily subcutaneous injections of 20 m/d TPTD were started. After 4 months of the therapy, fixture removal and sequestrectomy were performed. Histological analysis revealed necrotic lamellar bone and empty osteocytic lacunae. In contrast, multiple irregular reversal lines of the lamellar bone and active osteoblasts were noted adjacent to the lesion. There was a significant increase in serum C-terminal telopeptide cross-link of type 1 collagen and serum osteocalcin after commencement of the therapy. After 7 months off therapy, the serum levels of the 2 markers remained at a high level compared with the baseline.

Original languageEnglish
Pages (from-to)222-226
Number of pages5
JournalImplant dentistry
Issue number2
Publication statusPublished - 2015 Apr 4


All Science Journal Classification (ASJC) codes

  • Oral Surgery

Cite this